Aspire Biopharma Holdings, Inc. (ASBP)
5.30
+0.13
(+2.51%)
USD |
NASDAQ |
May 13, 16:00
5.30
0.00 (0.00%)
After-Hours: 20:00
Aspire Biopharma Holdings Profit Margin (Quarterly) : -109.5K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
| Veru, Inc. | -- |
| IGC Pharma, Inc. | -207.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -1.80K% |
| Gross Profit Margin (Quarterly) | -23.26% |
| Operating Margin (Quarterly) | -43.01K% |
| Return on Net Operating Assets | -42.41K% |